In the cystic fibrosis (CF) airway, chronic infection by Pseudomonas aeruginosa results from biofilm formation in a neutrophil-rich environment. We tested the capacity of human neutrophils to modify early biofilm formation of P. aeruginosa strain PAO1, and an isogenic CF strain isolated early and years later in infection. In a static reactor, P. aeruginosa biofilm density of all strains was enhanced at 24 h in the presence of neutrophils, with the greatest relative increase associated with the lowest inoculum of P. aeruginosa tested. Previously, neutrophil-induced biofilm enhancement was shown to largely result from the incorporation of F-actin and DNA polymers into the bacterial biofilm. This finding was advanced by the comparison of biofilm enhancement from intact unstimulated neutrophils and from lysed or apoptotic neutrophils. Apoptotic neutrophils, with an intact cell membrane, were unable to contribute to biofilm enhancement, while lysed neutrophils evoked a similar response to that of intact cells. Using F-actin and DNA as targets, the capacity of negatively charged poly(amino acids) to disrupt, or prevent, early biofilm formation was tested. Anionic poly(aspartic acid) effectively prevented or disrupted biofilm formation. Combination of poly(aspartic acid) with DNase resulted in a synergistic increase in biofilm disruption. These results demonstrate that the presence of dying neutrophils can facilitate the initial stages of biofilm development by low inocula of P. aeruginosa. Neutrophil F-actin represents a potential new therapeutic target for disruption of pathogenic biofilms.
BaumgartnerA.,
GrandM.2006; Bacteriological quality of drinking water from dispensers (coolers) and possible control measures. J Food Prot 69:3043–3046
CostertonJ. W.,
ChengK. J.,
GeeseyG. G.,
LaddT. I.,
NickelJ. C.,
DasguptaM.,
MarrieT. J.1987; Bacterial biofilms in nature and disease. Annu Rev Microbiol 41:435–464[CrossRef]
EmersonJ.,
RosenfeldM.,
McNamaraS.,
RamseyB.,
GibsonR. L.2002; Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34:91–100[CrossRef]
GibsonR. L.,
BurnsJ. L.,
RamseyB. W.2003; Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918–951[CrossRef]
HaslettC.,
GuthrieL. A.,
KopaniakM. M.,
JohnstonR. B.Jr,
HensonP. M.1985; Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119:101–110
HoffmannN.,
LeeB.,
HentzerM.,
RasmussenT. B.,
SongZ.,
JohansenH. K.,
GivskovM.,
HoibyN.2007; Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr −/− mice. Antimicrob Agents Chemother 51:3677–3687[CrossRef]
KhanT. Z.,
WagenerJ. S.,
BostT.,
MartinezJ.,
AccursoF. J.,
RichesD. W.1995; Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151:1075–1082
KhanN. H.,
IshiiY.,
Kimata-KinoN.,
EsakiH.,
NishinoT.,
NishimuraM.,
KogureK.2007; Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb Ecol 53:173–186[CrossRef]
KlausenM.,
HeydornA.,
RagasP.,
LambertsenL.,
Aaes-JorgensenA.,
MolinS.,
Tolker-NielsenT.2003; Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48:1511–1524[CrossRef]
LethemM. I.,
JamesS. L.,
MarriottC.,
BurkeJ. F.1990; The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 3:19–23
MoskowitzS. M.,
FosterJ. M.,
EmersonJ.,
BurnsJ. L.2004; Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42:1915–1922[CrossRef]
OgleJ. W.,
JandaJ. M.,
WoodsD. E.,
VasilM. L.1987; Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa
. J Infect Dis 155:119–126[CrossRef]
OntenienteL.,
BrisseS.,
TassiosP. T.,
VergnaudG.2003; Evaluation of the polymorphisms associated with tandem repeats for Pseudomonas aeruginosa strain typing. J Clin Microbiol 41:4991–4997[CrossRef]
ParadR. B.,
GerardC. J.,
ZurakowskiD.,
NicholsD. P.,
PierG. B.1999; Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun 67:4744–4750
PerksB.,
ShuteJ. K.2000; DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics. Am J Respir Crit Care Med 162:1767–1772[CrossRef]
ProsserB. L.,
TaylorD.,
DixB. A.,
CleelandR.1987; Method of evaluating effects of antibiotics on bacterial biofilm. Antimicrob Agents Chemother 31:1502–1506[CrossRef]
RoghanianA.,
DrostE. M.,
MacNeeW.,
HowieS. E.,
SallenaveJ. M.2006; Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am J Respir Crit Care Med 174:1189–1198[CrossRef]
SchaedelC.,
de MonestrolI.,
HjelteL.,
JohannessonM.,
KornfaltR.,
LindbladA.,
StrandvikB.,
WahlgrenL.,
HolmbergL.2002; Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 33:483–491[CrossRef]
SheilsC. A.,
KasJ.,
TravassosW.,
AllenP. G.,
JanmeyP. A.,
WohlM. E.,
StosselT. P.1996; Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol 148:919–927
SriramuluD. D.,
LünsdorfH.,
LamJ. S.,
RömlingU.2005; Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54:667–676[CrossRef]
van SchaikE. J.,
GiltnerC. L.,
AudetteG. F.,
KeizerD. W.,
BautistaD. L.,
SlupskyC. M.,
SykesB. D.,
IrvinR. T.2005; DNA binding: a novel function of Pseudomonas aeruginosa type IV pili. J Bacteriol 187:1455–1464[CrossRef]
WhitlockB. B.,
GardaiS.,
FadokV.,
BrattonD.,
HensonP. M.2000; Differential roles for α Mβ 2 integrin clustering or activation in the control of apoptosis via regulation of Akt and ERK survival mechanisms. J Cell Biol 151:1305–1320[CrossRef]